CME Group Inc.
CME · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $6,130 | $5,579 | $5,019 | $4,690 |
| % Growth | 9.9% | 11.1% | 7% | – |
| Cost of Goods Sold | $850 | $829 | $753 | $837 |
| Gross Profit | $5,280 | $4,750 | $4,266 | $3,853 |
| % Margin | 86.1% | 85.1% | 85% | 82.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $133 | $144 | $137 | $152 |
| SG&A Expenses | $133 | $144 | $137 | $152 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1,216 | $1,170 | $1,113 | $1,056 |
| Operating Expenses | $1,348 | $1,315 | $1,250 | $1,208 |
| Operating Income | $3,932 | $3,436 | $3,016 | $2,645 |
| % Margin | 64.1% | 61.6% | 60.1% | 56.4% |
| Other Income/Exp. Net | $610 | $718 | $474 | $728 |
| Pre-Tax Income | $4,541 | $4,154 | $3,490 | $3,374 |
| Tax Expense | $1,016 | $927 | $799 | $737 |
| Net Income | $3,526 | $3,226 | $2,691 | $2,636 |
| % Margin | 57.5% | 57.8% | 53.6% | 56.2% |
| EPS | 9.69 | 8.87 | 7.41 | 7.3 |
| % Growth | 9.2% | 19.7% | 1.5% | – |
| EPS Diluted | 9.67 | 8.86 | 7.4 | 7.29 |
| Weighted Avg Shares Out | 359 | 359 | 359 | 358 |
| Weighted Avg Shares Out Dil | 360 | 360 | 359 | 359 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $161 | $159 | $163 | $167 |
| Depreciation & Amortization | $337 | $353 | $363 | $385 |
| EBITDA | $5,039 | $4,666 | $4,016 | $3,926 |
| % Margin | 82.2% | 83.6% | 80% | 83.7% |